Focused on the development of instrumentation for the prediction of sudden cardiac death (SCD).

Fen EP Ltd is developing instrumentation for the prediction of sudden cardiac death, which can be a major issue for physicians, and health care providers.

The Company’s device is intended to enable interpretation of complex data and enable clinicians to assess patients as high, medium or low risk. Patients considered low risk could then be managed by alternative methods and therefore may not need surgery.

  • Product

    Life Sciences SEIS
  • Sector

    Sudden Cardiac Death prevention
  • Status

    Closed
  • HMRC

    Advanced Assurance